DRAPER, Utah, May 27, 2026 /PRNewswire/ — The FDA recently announced it is shifting regulatory attention and investment for emerging psychedelic-based therapeutics treating mental health conditions. CenExel Clinical Research is answering this push with expansion to support psychedelic…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
The dog training franchise has climbed 80 spots from its 2023 ranking and stands among some of the best-performing concepts in the industry. SANDY, Utah, Jan. 30, 2024 /PRNewswire-PRWeb/ — Dog Training Elite, the dog […]
LEHI, Utah, Jan. 14, 2026 /PRNewswire/ — eLuma, a leading provider of behavioral health and special education services for K-12 schools, announced the release of its second annual 2025 State of Student Mental Health Report, […]
Company’s generic droxidopa capsules demonstrate value of transparent, collaborative business model Cost to be about $2,100 per month less than the average cost1 for someone with Medicare Part D LEHI, Utah, April 10, 2025 /PRNewswire/ […]
Copyright © 2026 Biotech Networks
